Evans Carl Anthony has filed 5 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 17500 shares of CNS Pharmaceuticals, Inc. ($CNSP) on April 08, 2024.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Evans Carl Anthony | Director | A | Option to purchase common stock | 17500 | $0.00 | 129,594.0000 | 0 | 15.61% | 0.00% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Evans Carl Anthony | Director | A | Restricted Stock Units | 17500 | $0.00 | 147,094.0000 | 0 | 13.50% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Evans Carl Anthony | Director | P | Common stock | 33333 | $0.30 | 33,458.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Evans Carl Anthony | Director | A | Series A Warrant to purchase common stock | 33333 | $0.00 | 78,761.0000 | 0 | 73.38% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Evans Carl Anthony | Director | A | Series B Warrant to purchase common stock | 33333 | $0.00 | 112,094.0000 | 0 | 42.32% | 0.00% |